No Data
AstraZeneca Earnings Expected to Rise With Focus on China -- Earnings Preview
Report Says 25% Pharma Tariff Would Raise US Drug Prices by $51 Billion Annually, Reuters Reports
SOPHiA GENETICS Announces Expanded Collaboration With AstraZeneca to Accelerate Liquid Biopsy Testing Globally From AACR
HSBC Maintains AstraZeneca(AZN.US) With Buy Rating, Raises Target Price to $79
J.P. Morgan Reaffirms Their Buy Rating on AstraZeneca (AZN)
Earnings Week Ahead: MSFT, AAPL, META, AMZN, QCOM, PFE, MA, V, PYPL, ROKU, MCD, SBUX, KO, and More